Keywords: pancreatic cancer, GLP-1 receptor, pancreatitis Abstract Background : Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have advanced the treatment of type 2 diabetes mellitus (T2DM), yet their association with cancer risk remains subject of ongoing research
Methionine An essential amino acid that supports the liver in processing fatty acids, lowers cholesterol, and prevents excess fat buildup
This type of medication, known as GLP-1 drugs and originally developed to treat type 2 diabetes, have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion
It screens for personal or family history of medullary thyroid carcinoma, MEN-2, pancreatitis, severe gastroparesis, pregnancy, and other contraindications
Weight loss drugs linked to dozens of deaths